Sabby Management, LLC Lipocine Inc. Transaction History

Sabby Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.2 - $1.69 $532,162 - $749,462	-443,469 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.21 - $2.23 $519,110 - $956,707	429,017 Added 2968.56%	443,469 $625,000
Q2 2020 Aug 14, 2020	BUY	$0.42 - $1.26 $6,069 - $18,209	14,452 New	14,452 $18,000
Q1 2020 May 15, 2020	SELL	$0.32 - $0.77 $117,661 - $283,123	-367,693 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.32 - $3.15 $117,661 - $1.16 Million	367,693 New	367,693 $142,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $496M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.